电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

PRAME 抗体 (AA 321-509)

This anti-PRAME antibody is a 兔 多克隆 antibody detecting PRAME in WB. Suitable for 人.
产品编号 ABIN1589821
发货至: 中国

Quick Overview for PRAME 抗体 (AA 321-509) (ABIN1589821)

抗原

See all PRAME 抗体
PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))

适用

  • 56
  • 20
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1

宿主

  • 54
  • 2

克隆类型

  • 55
  • 1
多克隆

标记

  • 29
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This PRAME antibody is un-conjugated

应用范围

  • 28
  • 16
  • 13
  • 13
  • 10
  • 8
  • 6
  • 5
  • 4
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB)
  • 抗原表位

    • 16
    • 10
    • 5
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 321-509

    原理

    PRAME antibody

    特异性

    Recombinant human PRAME (Met321-Asn509)

    免疫原

    Recombinant human PRAME (Met321-Asn509)

    亚型

    IgG
  • 应用备注

    Western Blot: Use 1-5 μg/mL

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

    缓冲液

    PBS

    注意事项

    Centrifuge vial prior to opening.

    储存条件

    4 °C,-20 °C

    储存方法

    The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.

    有效期

    24 months
  • 抗原

    PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))

    别名

    PRAME

    背景

    Melanoma antigen preferentially expressed in tumors, Opa-interacting protein 4, MAPE, OIP4,PRAME/MAPE/OIP4 is a germinal tissue-specific gene that is also expressed at high levels in haematological malignancies and solid tumors. The physiological functions of PRAME in normal and tumor cells are unknown, although a role in the regulation of retinoic acid signaling has been proposed. Sequence homology and structural predictions suggest that PRAME is related to the Leucine-rich repeat (LRR) family of proteins, which have diverse functions. PRAME, or ""preferentially expressed antigen in melanoma"", was originally identified as a gene encoding a HLA-A24 restricted antigenic peptide presented to autologous tumor-specific cytotoxic T lymphocytes derived from a patient with melanoma. PRAME is synonymous with MAPE (melanoma antigen preferentially expressed in tumors) and OIP4 (OPA-interacting protein 4), and its expression profile defines it as a cancer-testis antigen. Cancer-testis antigens (CTAs) are encoded by non-mutated genes expressed at high levels in germinal tissues and tumors, but which are absent from or detected at low levels in other tissues. PRAME may be somewhat different to other cancer-testis antigens in that it shows some expression in normal tissues such as ovary, adrenal, placenta and endometrium. The C-terminus of human PRAME (amino acids 453-509) was also identified to bind Neisseria gonorrhoeae opacity factors, in this case the OPA-P protein. Thus PRAME is also known as OIP4 (OPA interacting protein),

    基因ID

    23532

    NCBI登录号

    NM_006115, NP_006106

    UniProt

    P78395

    途径

    Retinoic Acid Receptor Signaling Pathway, Nuclear Hormone Receptor Binding
You are here:
Chat with us!